In vivo biomechanical assessment of triglycidylamine crosslinked pericardium
Source abstract
Abstract
While glutaraldehyde crosslinking is most often used to fabricate bioprosthetic heart valves (BHV) using heterograft tissues, it predisposes BHV to calcification and dramatically stiffens the heterograft tissues. Our group previously reported the synthesis and characterization of a novel epoxy-crosslinker, triglycidylamine (TGA). TGA pretreatment of BHV tissues compared to glutaraldehyde results in both calcification resistance in subdermal implants and improved leaflet compliance. In these prior studies, optimal calcification inhibition was noted with the combined use of TGA with mercapto-aminobisphosphonate (MABP). In the present study, we investigated the hypothesis that bovine pericardium cross-linked with TGA-MABP retains these beneficial biomechanical properties in vivo using a novel mitral valve anterior leaflet (MVAL) ovine valvuloplasty model. Bovine pericardial specimens were crosslinked with either glutaraldehyde or TGA-MABP, from which 1cm2 sections were implanted in the ovine MVAL after removal of the original tissue of the same size. An array of four sonomicrometry transducers were implanted on the corners and used to compute the complete in-surface strain tensor cardiac cycle over the cardiac cycle at 0 and 4 weeks. Following explant samples were fixed in formalin for histology studies. At 4 weeks both treatment groups experienced no dimensional changes in the unloaded state, indicating no shrinkage. When fully loaded during peak systolic ejection, TGA-MABP valvuloplasty patches were significantly more compliant, which did not change at 4 weeks. In contrast, the glutaraldehyde areal strain increased significantly by 4 weeks. Estimated implant stresses for both treatment groups, based on previously measured biomechanical properties [Connolly JM, Alferiev I, Clark-Gruel JN, Eidelman N, Sacks M, Palmatory E, et al. Triglycidylamine crosslinking of porcine aortic valve cusps or bovine pericardium results in improved biocompatibility, biomechanics, and calcification resistance: chemical and biological mechanisms. Am J Pathol 2005;166(1):1-13], were 40 and 250 kPa in the circumferential and radial directions, respectively, which are comparable to predicted BHV peak stress levels. We conclude that TGA-MABP crosslinked bovine pericardium, when subjected to in vivo BHV stress levels in a blood-contacting environment, maintains stable functionality.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Elasticity and Material Modeling · Cardiovascular Function and Risk Factors · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (33)
Show source-provided references
1. Calcification of tissue heart valve substitutes: progress toward understanding and prevention10.1016/j.athoracsur.2004.06.033 ↗
2. Editorial: are immune mechanisms important in tissue heart valve failure? A debate
3. Collagen fiber disruption occurs independent of calcification in clinically explanted bioprosthetic heart valves10.1002/jbm.10293 ↗
4. Biomechanical and structural properties of the explanted bioprosthetic valve leaftets10.1016/0021-9290(94)90027-2 ↗
5. Mineralization of glutaraldehyde-fixed porcine aortic valve cusps in the subcutaneous rat model: analysis of variations in implant site and cuspal quadrants10.1002/(SICI)1097-4636(19990605)45:3<209::AID-JBM8>3.0.CO;2-N ↗
6. Structural changes in porcine bioprosthetic valves of a left ventricular assist system in human patients
7. Triglycidylamine crosslinking of porcine aortic valve cusps or bovine pericardium results in improved biocompatibility, biomechanics, and calcification resistance: chemical and biological mechanisms10.1016/S0002-9440(10)62227-4 ↗
8. Mechanisms of the in vivo inhibition of calcification of bioprosthetic porcine aortic valve cusps and aortic wall with triglycidylamine/mercapto bisphosphonate10.1016/j.biomaterials.2006.09.029 ↗
9. Bioprosthetic heart valve heterograft biomaterials: structure, mechanical behavior and computational simulation10.1586/17434440.3.6.817 ↗
10. Heart valve function: a biomechanical perspective10.1098/rstb.2007.2122 ↗
11. Incorporation of experimentally-derived fiber orientation into a structural constitutive model for planar collagenous tissues10.1115/1.1544508 ↗
12. A novel mercapto-bisphosphonate as an efficient anticalcification agent for bioprosthetic tissues10.1016/j.jorganchem.2004.10.011 ↗
13. Dynamic three-dimensional imaging of the mitral valve and left ventricle by rapid sonomicrometry array localization10.1016/S0022-5223(96)70056-9 ↗
14. Surface strains in the anterior leaflet of the functioning mitral valve10.1114/1.1529194 ↗
15. In vivo 3-D reconstruction and geometric characterization of the right ventricular free wall10.1007/BF02368182 ↗
16. In-vivo dynamic deformation of the mitral valve anterior leaflet10.1016/j.athoracsur.2006.03.117 ↗
17. Biaxial mechanical response of bioprosthetic heart valve biomaterials to high in-plane shear10.1115/1.1572518 ↗
18. Press · 1988
19. Biaxial mechanical properties of the native and glutaraldehyde-treated aortic valve cusp: part II—a structural constitutive model10.1115/1.1287158 ↗
20. Biaxial mechanical properties of the natural and glutaraldehyde treated aortic valve cusp—part I: experimental results10.1115/1.429624 ↗
21. Characteristics of compressive strains in porcine aortic valves cusps
22. Orthotropic mechanical properties of chemically treated bovine pericardium10.1114/1.135 ↗
23. Lee JM, Langdon SE. Biaxial mechanical changes in bovine pericardium cross-linked in EDC under controlled biaxial strain. In: 21st annual meeting of the society of biomaterials, 1995. p. 86.
24. Biaxial stress-stretch behavior of the mitral valve anterior leaflet at physiologic strain rates10.1007/s10439-005-9027-y ↗
25. Biaxial mechanical behavior of excised porcine mitral valve leaflets
26. Simulated bioprosthetic heart valve deformation under quasi-static loading10.1115/1.2049337 ↗
27. Biaxial mechanical evaluation of planar biological materials10.1023/A:1010917028671 ↗
28. Prosthetic Devices Branch, D.o.C., Respiratory and Neurological Devices, Replacement Heart Valve Guidance. Center for Devices and Radiological Health (FDA): Rockfied, MD; 1993.
29. Effects of mechanical fatigue on the bending properties of the porcine bioprosthetic heart valve10.1097/00002480-199901000-00014 ↗
30. Cyclic loading response of bioprosthetic heart valves: effects of fixation stress state on the collagen fiber architecture10.1016/j.biomaterials.2004.06.046 ↗
31. Effects of fixation pressure on the biaxial mechanical behavior of porcine bioprosthetic heart valves with long-term cyclic loading10.1016/S0142-9612(01)00375-1 ↗
32. The influence of design on bioprosthetic valve durability
33. Pathology of substitute heart valves10.1111/j.1540-8191.1994.tb00932.x ↗